Researchers analyzed data from over 2,300 patients to evaluate how well certain factors predict the risk of invasive pulmonary aspergillosis (IPA) or similar fungal infections in people with severe fever with thrombocytopenia syndrome (SFTS). The study looked at three main indicators: neurological symptoms, ICU admission, and the use of corticosteroids.
The results showed that neurological symptoms were a clear indicator of increased risk. While ICU admission and corticosteroid use also showed links to higher risk, these findings were less precise. In a smaller group of 220 patients, a specific three-variable tool was tested. This tool showed high accuracy in identifying those at risk, with infection rates rising from 3.7% in low-risk groups to over 83% in high-risk groups.
It is important to note that this tool is meant for risk stratification and does not replace clinical judgment. Because the data used to validate the tool came from a single center, it may not apply perfectly to every patient. This finding helps doctors decide where to focus more intensive testing and monitoring.
